HUMINT in Pharma – Why Superior Primary Research Gives an Edge in Competitive Intelligence In the pharmaceutical industry, information is power. Decisions on R&D, licensing, and product launches can involve…
Key Issues Biotech and Pharma Companies Must Address to Succeed in Out-Licensing Pharma and biotech out-licensing and partnering are essential growth drivers for innovative life sciences companies. Yet, despite repeated…
Leveraging EBITDA Multiples for Accurate Pharma Company Valuations Determining the valuation of pharmaceutical and biotechnology companies is a crucial exercise to inform high-impact decisions including organic investments and prioritization, licensing…
The Pharma CI Threat Matrix: How to Prioritize Threats in the Pharma Competitive Intelligence In today's rapidly evolving pharmaceutical landscape, companies face an overwhelming array of competitive threats. From emerging…
Understanding and Applying Discount Rates for Precise Biopharma Valuations Selecting the appropriate discount rate is essential for pharmaceutical and biotechnology valuations. The discount rate is one of the key drivers…
A Comprehensive Guide to Pharmaceutical Competitive Intelligence The pharmaceutical industry is fiercely competitive, with companies constantly seeking to win in the marketplace. Pharmaceutical competitive intelligence is a decision-making tool, and…
AI in Pharmaceutical Competitive Intelligence In today's rapidly evolving pharmaceutical landscape, competitive intelligence is undergoing a profound transformation through artificial intelligence (AI) and advanced analytics. While these technologies provide unprecedented…
How to Conduct Advanced Competitive Benchmarking in the Biopharma Industry In the fiercely competitive landscape of the biopharmaceutical industry, staying ahead requires not just innovation but also a keen understanding…
Mastering the Valuation of Pharma and Biotech Assets and Businesses Properly valuing drug and biotechnology assets is essential for pharmaceutical enterprises, biotech companies, investors, and other healthcare stakeholders. Valuation provides…
How to Extract Competitive Intelligence from Phase 3 Trials In the high-stakes world of pharmaceutical development, Phase 3 clinical trials represent the culmination of years of research and billions in…